US Transhumanist Party rocked by furore over “lab-grown human meat” project
By Jonathan Matthews,
GMWatch
| 07. 06. 2020
“Cannibalism of any sort and by any means, including auto-cannibalism, is not tolerated by the USTP.”
Transhumanists are no strangers to controversy. How could they be when Jeffrey Epstein numbered himself among their longstanding adherents and hefty financial backers? But even by transhumanist standards, the ructions that have just rocked the US Transhumanist Party (USTP) over their 2020 Presidential candidate have been remarkable.
Transhumanists, as you may know, are extreme technophiles who want to use genetic engineering and other extreme technologies, including neural interfaces with machines (i.e. implanting hardware in their brains that connects to a computer or other cyber device), in order to “enhance” themselves in pursuit of what they call “humanity 2.0”, “humanity plus” or “posthumanity”.
Transhumanists are also keen on gaining immortality and, as this isn’t immediately on offer, this tends to go hand in hand with an interest in cryonics – freezing all or parts of their bodies when dead (Epstein is said to have wanted his brain and his penis preserved) in the hope of resurrection at some suitable future juncture.
Sound nuts? Well, it seems to have real appeal for the kind of affluent geeks forever in pursuit of the...
Related Articles
By John H. Evans, Craig Callender, Neal K. Devaraj, Farren J. Isaacs, and Gregory E. Kaebnick, Issues in Science and Technology | 07.04.2025
The controversy around a ban on “mirror life” should lead to a more nuanced public conversation about how to manage the benefits and risks of precursor biotechnologies.
About five years ago, the five of us formed a discussion group to...
By Geoffrey A. Fowler, The Washington Post | 07.17.2025
Nearly 2 million people protected their privacy by deleting their DNA from 23andMe after it declared bankruptcy in March. Now it’s back with the same person in charge — and I still don’t trust it.
Nor do the attorneys general...
By Angus Liu, Fierce Pharma | 07.22.2025
A brief skirmish between Sarepta Therapeutics and the FDA has ended before escalating into a full-on regulatory clash, as the company has bowed to the agency’s demand.
In a surprising reversal, Sarepta on Monday said it will pause all shipments...
By Rob Stein, NPR | 07.16.2025
Scientists can protect children from being born with certain devastating genetic disorders by creating "three-parent" babies, according to the results of a landmark study released Wednesday.
British researchers used the experimental technique to help families have eight children who appear...